{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-21-006167","form_type":"8-K","ticker":"BCRX","cik":"0000882796","company_name":"BIOCRYST PHARMACEUTICALS INC","filed_at":"2021-08-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.060920+00:00","generated_at":"2026-06-29T07:43:19.829621+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"BioCryst appoints former FDA CDER director Steven Galson to board of directors","bullets":["Board expanded from 9 to 10; Galson effective Sept 1, 2021, term ends at 2022 annual meeting.","Galson is former FDA CDER director, acting U.S. surgeon general, and ex-SVP R&D at Amgen.","Receives automatic grant of 60,000 stock options upon joining, plus 40,000 annually subject to tenure.","Appointed to Science Committee; compensation per company's director compensation policy."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-21-006167","json":"https://secwatch.observer/filing/0001171843-21-006167.json","markdown":"https://secwatch.observer/filing/0001171843-21-006167.md","text":"https://secwatch.observer/filing/0001171843-21-006167.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882796/000117184321006167/0001171843-21-006167-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882796/000117184321006167/f8k_082621.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T07:43:19.829621+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f4f98c73e7","claim":"Steven Galson was appointed as Director at BIOCRYST PHARMACEUTICALS INC.","evidence_excerpt":"elected Steven Galson, M.D. to fill the vacancy created by the enlargement of the Board, effective September 1, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882796/000117184321006167/0001171843-21-006167-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}